← Back to Search

Neuropsychological Consultation for Diabetes

N/A

Waitlist Available

Led By Mary Gallagher, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9 months

Awards & highlights

Study Summary

This trial will compare two groups of children with diabetes, one that will receive neuropsychological consultations as part of their care and one that will not, to see if the consultations improve glycemic control and quality of life.

Eligible Conditions

Diabetes
Glycinemia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Improved Glycemic Control measured by assessment of glycemic control (HgbA1C)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Neuropsychological Consultation GroupExperimental Treatment1 Intervention

Children will be administered a number of neuropsychological tests. Children and parents in Group 2 will also complete a pediatric quality of life scale (PedsQL, Generic Scale and Diabetes Module), diabetes related family conflict scale (DFCS-R) to assess quality of life and family stress at the start of the study, as well as the self-report form of the BRIEF-2 if they are over age 11. Parents will also undergo a brief literacy and numeracy screening using the Wide Range Achievement Test, complete a parent report assessing their children's executive functioning skills at the start of the study (BRIEF-2) and they will fill out the Family Impact Module.

Group II: Control GroupActive Control1 Intervention

Usual standard of care from their diabetes care team

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Neuropsychological Consultation

2019

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,367 Previous Clinical Trials

839,671 Total Patients Enrolled

17 Trials studying Diabetes

20,202 Patients Enrolled for Diabetes

Mary Gallagher, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants aged thirty and older accepted for this research?

"This trial requires patients to be between 10 and 18 years old. As of now, there are 198 studies involving minors, as well as 950 trials that accommodate individuals over 65."

Answered by AI

Are there any vacancies for potential participants in this trial?

"Clinicaltrials.gov support the fact that recruitment for this medical study has been inactive since August 4th 2022. Originally posted on July 16th 2019, it is not currently seeking volunteers; however, there are 1,266 other studies actively recruiting patients now."

Answered by AI

Am I eligible to be a participant in this trial?

"To qualify for this diabetes trial, the applicant must have a diagnosis of diabetes mellitus and be between 10-18 years old. Approximately 50 participants are currently sought after."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Neuropsychological Consultation as Part of Pediatric Diabetes Care: Does it Improve Glycemic Control and Family Functioning?

2019. "Neuropsychological Consultation as Part of Pediatric Diabetes Care: Does it Improve Glycemic Control and Family Functioning?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03653013.